Scarica l'app Stockscreener
3.67
2.65%
-0.10
Dopo l'orario di chiusura:
3.67
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.77
Aprire:
$3.69
Volume 24 ore:
258.13K
Relative Volume:
0.42
Capitalizzazione di mercato:
$232.28M
Reddito:
-
Utile/perdita netta:
$-45.08M
Rapporto P/E:
-5.0274
EPS:
-0.73
Flusso di cassa netto:
$-33.68M
1 W Prestazione:
-2.65%
1M Prestazione:
+46.22%
6M Prestazione:
+182.31%
1 anno Prestazione:
+63.11%
Intervallo 1D:
$3.55
$3.7643
Intervallo di 1 settimana:
$3.55
$4.41
Portata 52W:
$0.726
$4.41
Galectin Therapeutics Inc Stock (GALT) Company Profile
Nome
Galectin Therapeutics Inc
Settore
Industria
Telefono
678-620-3186
Indirizzo
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Confronta GALT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GALT
Galectin Therapeutics Inc
|
3.67 | 238.61M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-13 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-13 | Iniziato | B. Riley FBR | Buy |
| 2017-12-07 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-28 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-19 | Iniziato | ROTH Capital | Buy |
| 2017-03-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2016-10-03 | Downgrade | FBR & Co. | Outperform → Mkt Perform |
| 2016-09-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2016-09-28 | Downgrade | ROTH Capital | Buy → Sell |
| 2016-03-28 | Ripresa | H.C. Wainwright | Buy |
| 2015-09-21 | Iniziato | H.C. Wainwright | Buy |
| 2014-08-01 | Downgrade | Aegis Capital | Buy → Hold |
| 2014-07-30 | Reiterato | MLV & Co | Buy |
| 2014-07-29 | Reiterato | MLV & Co | Buy |
| 2014-04-02 | Reiterato | MLV & Co | Buy |
| 2014-02-10 | Reiterato | Aegis Capital | Buy |
| 2014-01-09 | Reiterato | Aegis Capital | Buy |
| 2013-12-03 | Iniziato | MLV & Co | Buy |
| 2013-08-19 | Reiterato | Aegis Capital | Buy |
Mostra tutto
Galectin Therapeutics Inc Borsa (GALT) Ultime notizie
What recovery options are there for Galectin Therapeutics Inc.2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - Newser
Will Galectin Therapeutics Inc. stock recover after recent dropIPO Watch & Weekly Top Stock Performers List - Newser
What data driven models say about Galectin Therapeutics Inc.’s futureProfit Target & Low Risk Entry Point Guides - Newser
Quantitative breakdown of Galectin Therapeutics Inc. recent movePortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
How institutional ownership impacts Galectin Therapeutics Inc. stockEarnings Beat & Stepwise Trade Signal Implementation - Newser
Galectin Therapeutics (NASDAQ:GALT) Share Price Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Top Risks to Consider Before Buying Galectin Therapeutics Inc. StockAI Powered Buy Point Forecast Planner - Newser
Earnings visualization tools for Galectin Therapeutics Inc.Free Capital Growth With Controlled Risk Picks - Newser
Predicting Galectin Therapeutics Inc. trend using moving averagesChart Scanner for Swing Trade Timing - Newser
Galectin Therapeutics Inc. stock trend outlook and recovery pathLow Drawdown Picks with Weekly Updates - Newser
Signal strength of Galectin Therapeutics Inc. stock in tech scannersFree Fast Entry High Potential Stock Alerts - Newser
What the charts say about Galectin Therapeutics Inc. todayRisk/Reward Optimization Entry Point Analysis - Newser
How Galectin Therapeutics Inc. stock performs during market volatilityDaily Swing Candidate Analysis with Chart Patterns - Newser
Does Galectin Therapeutics Inc. show high probability of reboundFree Buy Signal Based on Chart Analysis - Newser
Galectin Therapeutics (GALT) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Galectin GALT 2025Q2 Earnings Preview Upside Potential on Immunotherapy Advancements - AInvest
Combining price and volume data for Galectin Therapeutics Inc.Downside Risk Evaluation and Stock Analysis - Newser
Galectin Therapeutics Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Strategies to average down on Galectin Therapeutics Inc.Smart Entry Watchlist with Daily Analysis - Newser
Published on: 2025-08-07 02:32:09 - Newser
Is it time to cut losses on Galectin Therapeutics Inc.Watchlist Generator for Smart Money Signals - Newser
What makes Galectin Therapeutics Inc. stock price move sharplyFree Capital Protection Trading Strategies - Newser
Galectin Therapeutics Inc Azioni (GALT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):